Cargando…
Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome
Deficiency in homologous recombination repair (HRR) is frequently associated with hormone-responsive cancers, especially the epithelial ovarian cancer (EOC) which shows defects of HRR in up to half of cases. However, whether there are molecular connections between estrogen signaling and HRR deficien...
Autores principales: | Hao, Dapeng, Li, Jingjing, Wang, Jianlin, Meng, Yuan, Zhao, Zhiqiang, Zhang, Chao, Miao, Kai, Deng, Chuxia, Tsang, Benjamin K., Wang, Li, Di, Li-jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587348/ https://www.ncbi.nlm.nih.gov/pubmed/31281524 http://dx.doi.org/10.7150/thno.30814 |
Ejemplares similares
-
Epigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy
por: Li, Jingjing, et al.
Publicado: (2017) -
SB225002 Promotes Mitotic Catastrophe in Chemo-Sensitive and -Resistant Ovarian Cancer Cells Independent of p53 Status In Vitro
por: Du, Meirong, et al.
Publicado: (2013) -
Metabolic modulation of CtBP dimeric status impacts the repression of DNA damage repair genes and the platinum sensitivity of ovarian cancer
por: Li, Jingjing, et al.
Publicado: (2023) -
Lovastatin Inhibits Cancer Stem Cells and Sensitizes to Chemo- and Photodynamic Therapy in Nasopharyngeal Carcinoma
por: Peng, Yikun, et al.
Publicado: (2017) -
The Roles of Exosomes in Ovarian Cancer Chemo-resistance
por: Liu, Yang, et al.
Publicado: (2023)